Home » interviews » Developing basic technology for personalized medicine: Dr. Paidi Yella Reddy, Founder & CEO, Sapala Organics

Developing basic technology for personalized medicine: Dr. Paidi Yella Reddy, Founder & CEO, Sapala Organics

Developing basic technology for personalized medicine: Dr. Paidi Yella Reddy, Sapala Organics

  • November 24, 2025

Interviews

Only 4-5 I
Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Only 4-5 I
Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Companies
Companies must shift from L1 costing to Life Cycle Cost Analysis: Abhilash Pasham, Associate GM - Central Engineering & Projects, Dr. Reddy's Laboratories
View More

Appointments

Jubilant Ingrevia appoints Pravesh Kumar Garg as Chief of Manufacturing
Jubilant Ingrevia appoints Pravesh Kumar Garg as Chief of Manufacturing
Thyrocare appoints Rajdeep Panwar as Chief Commercial Officer
Thyrocare appoints Rajdeep Panwar as Chief Commercial Officer
AstraZeneca elevates Vikram Chand as SVP, Head of R&D for Japan
AstraZeneca elevates Vikram Chand as SVP, Head of R&D for Japan
View More

Startup

Excelsior Sciences raises $95 million for drug discovery with AI-ready chemistry
Excelsior Sciences raises $95 million for drug discovery with AI-ready chemistry
EIB, Angelini Ventures team up to pump €150 million into European biotech, digital health startups
EIB, Angelini Ventures team up to pump €150 million into European biotech, digital health startups
Teva launches 'Teva Rise' to harness global innovation and transform healthcare
Teva launches 'Teva Rise' to harness global innovation and transform healthcare
View More

Digitization

TAKE Solutions plans AI-driven healthcare platform
TAKE Solutions plans AI-driven healthcare platform
Roche unveils major upgrade to cobas 6800/8800 systems, boosting lab efficiency
Roche unveils major upgrade to cobas 6800/8800 systems, boosting lab efficiency
Revvity unveils AI-powered Signals Xynthetica to accelerate molecular and materials design
Revvity unveils AI-powered Signals Xynthetica to accelerate molecular and materials design
View More

Latest Stories

Shilpa Medicare aims for US approval of chemo nausea drug

Granules Pharmaceuticals secures FDA tentative approval and 180-day exclusivity for Generic Dyanavel XR

IMCD opens beauty, personal Care laboratory in California

Alkem launches innovative hair growth support therapy kit

GSK secures European nod for easier-to-use Shingrix prefilled syringe

Opinion
Reimagining India’s Pharmaceutical Sector: From Global Supplier to Innovation Leader
Reimagining India’s Pharmaceutical Sector: From Global Supplier to Innovation Leader
Metal-free catalysis is transforming future of sustainable pharmaceutical innovation
Metal-free catalysis is transforming future of sustainable pharmaceutical innovation

Interviews
Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Companies must shift from L1 costing to Life Cycle Cost Analysis: Abhilash Pasham, Associate GM - Central Engineering & Projects, Dr. Reddy's Laboratories
Companies must shift from L1 costing to Life Cycle Cost Analysis: Abhilash Pasham, Associate GM - Central Engineering & Projects, Dr. Reddy's Laboratories

Packaging